Advertisement

Document › Details
Agilent Technologies Inc.. (8/8/18). "Press Release: Agilent Announces Update on PD-L1 CE-IVD in Urothelial Carcinoma". Santa Clara, CA.
![]() |
Region | EU (European Union) |
![]() |
Product | PD-L1 IHC 22-C3 pharmDx (Dako) |
![]() |
Person | Wadsworth-Hansen, Victoria (Agilent 201506 Director Global Business Public Relations) |
PD-L1 IHC 22C3 pharmDx Can Now Be Used as an Aid to Identify Urothelial Carcinoma Patients for Treatment With KEYTRUDA® (pembrolizumab)
Agilent Technologies Inc. (NYSE: A) today announced that its PD-L1 IHC 22C3 pharmDx assay is now labeled for an updated use in urothelial carcinoma in Europe.
Physicians in Europe can now use the assay as an aid to identify urothelial carcinoma patients who are ineligible for cisplatin and may respond to KEYTRUDA (pembrolizumab) as a first-line treatment option. KEYTRUDA is a targeted anti-PD-1 immunotherapy manufactured by Merck (known as MSD outside the United States and Canada). It is a humanized monoclonal antibody that may increase the ability of the body's immune system to help detect and fight tumor cells.
"We are pleased that PD-L1 IHC 22C3 pharmDx will help physicians identify urothelial carcinoma patients for whom KEYTRUDA may be an appropriate first-line treatment option. Being able to support the use of immuno-oncology therapeutics by bringing their associated diagnostics to market is truly encouraging," said Sam Raha, president of Agilent's Diagnostics and Genomics Group.
Agilent is a worldwide leader in partnering with pharmaceutical companies to develop immunohistochemical-based diagnostics for cancer therapy. Agilent developed PD-L1 IHC 22C3 pharmDx in partnership with Merck. PD-L1 expression in urothelial carcinoma tissues is interpreted using Combined Positive Score (CPS). PD-L1 IHC 22C3 pharmDx also helps physicians identify non-small cell lung cancer (NSCLC) patients for treatment with KEYTRUDA. PD-L1 expression in NSCLC tissues is interpreted using Tumor Proportion Score (TPS).
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenues of $4.47 billion in fiscal 2017 and employs 14,200 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to our Newsroom.
Contact
Victoria Wadsworth-Hansen
Agilent Technologies
+1 408 553 2005
+45 2933 6980
victoria.wadsworth-hansen@agilent.com
Record changed: 2018-08-11 |
Advertisement

More documents for Agilent (Group)
- [1] Agilent Technologies Inc.. (2/8/21). "Press Release: Agilent to Present at Upcoming Investor Events, Provides Webcast Details for Annual Shareholder Meeting". Santa Clara, CA....
- [2] Agilent Technologies Inc.. (2/1/21). "Press Release: Agilent Wins Trade Secret and Patent Infringement Litigation". Santa Clara, CA....
- [3] Agilent Technologies Inc.. (1/25/21). "Press Release: Agilent Announces Enhanced Mass Spectrometry and Automation Software Solutions to Support Regulatory Compliance Guidelines". Santa Clara, CA....
- [4] Agilent Technologies Inc.. (1/15/21). "Press Release: Agilent Names Allison Ballmer Senior Vice President of Corporate Development". Santa Clara, CA....
- [5] Agilent Technologies Inc.. (12/22/20). "Press Release: Agilent Receives Approval for GenetiSure Dx Postnatal Assay in Japan". Santa Clara, CA....
- [6] Agilent Technologies Inc.. (12/16/20). "Press Release: Agilent Announces Webcasts for Investment Community". Santa Clara, CA....
- [7] Agilent Technologies Inc.. (12/14/20). "Press Release: Agilent Receives Multiple Innovation Awards". Santa Clara, CA....
- [8] Agilent Technologies Inc.. (12/2/20). "Press Release: Agilent Announces New, Innovative 7850 ICP-MS System". Santa Clara, CA....
- [9] Agilent Technologies Inc.. (11/17/20). "Press Release: Agilent Presents Thought Leader Award to Drs. Carl H. June and Michael Milone". Santa Clara, CA....
- [10] Agilent Technologies Inc.. (8/27/20). "Press Release: Agilent Sets the Standard in Customer Flexibility with Analytical Technology Subscription Model". Santa Clara, CA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement

» top